Rennie is Head of Philanthropy and chairs Messrs. Hoare Trustees (MHT); this includes the bank’s donor advised fund, the Master Charitable Trust. Previously, he worked at T. Rowe Price and was responsible for relationships with institutional investment consultants in the UK and Europe. Before joining T. Rowe Price in 2011, he spent time at both Threadneedle and Guinness Asset Management. He graduated from the University of York with a BA Hons in Politics and holds the Investment Management Certificate.
Rennie chairs Philanthropy Impact and is a trustee of the David Nott Foundation. He particularly enjoys mentoring the next generation of philanthropists.
Nina Levin is a senior communications professional with extensive client-facing experience and a thorough understanding of corporate communications and internal and compliance processes. In her role as vice president of client success at Within3, she directs and identifies activities to meet KPIs by developing tailored strategic plans and drawing on experience across medical communications, advertising, and PR to set clients up for success.
Nina’s proven track record and industry expertise allows her to deliver and oversee client support activities and apply her experience in process development, improvement, and implementation to ensure optimal results while meeting timelines and providing cost-effective deliverables.
Fatima is passionate about elevating the patient voice on a global scale.
She believes that understanding patient experiences and challenges is essential to speeding up the development of life-changing medicines. Further, she advocates in support of patients gaining the skills, courage, and knowledge to navigate through a cancer diagnosis, to make informed decisions, and to ensure they can advocate for and achieve the best care possible.
This fierce passion and commitment to putting the needs of patients first is evident in her decades-long career where she is recognized as an influential global advocate thought leader focused on patient centered research, policy, access, and regulatory impact.
She has held multiple senior management positions in healthcare and is a respected member of the biopharma and cancer communities. Fatima has contributed to numerous publications in partnership with the advocacy community and key academic researchers to advance patient-centered care, as well as being included in the PharmaVOICE 100 in 2014 and receiving the Trailblazer Brand Champion Award from PM3670 in 2015
Tamieka Lauz Hunter joined Relay Therapeutics 1.5 years ago. Having worked for a multitude of pharmaceutical, biotechnology and CRO organizations over 12 years with primary therapeutic expertise in clinical execution of oncology programs. Her passion lies in precision medicine and bringing novel therapeutic options to patients with unmet need. Tamieka acquired a MSHS: Clinical Research Administration at George Washington University School of Medicine.
Danielle Sack is a leader, coach with over two decades of experience working in the financial sector, primarily creating large high performing teams throughout customer delivery. She is focused on delivering our strategy within a sustainable resilient business, delivering high customer experience across all channels of choice and committed to doing what matters, launching our first sustainable branch.
She is passionate about her people and customers, always looking at ways to best support the end user. Delivering clearer and higher expectations through centralised change programs.
Amna Mujahid is a Senior Analyst in GlobalData’s Strategic Intelligence team advising clients on the impacts of emerging technologies, macroeconomic trends, and key industry issues. Her core areas of expertise include demographics, aging populations, supply chain disruptions, AI, the future of work, and the creator economy. Amna has an undergraduate degree in English Language and Literature from the University of Oxford.
